Loading...
•
Mar 31, 2024
HCA Q1 2024 Earnings Report
HCA Healthcare's financial results for Q1 2024 were announced, showcasing revenue growth and increased net income.
Key Takeaways
HCA Healthcare reported strong first-quarter results, driven by broad-based volume growth. Revenues increased to $17.339 billion, and net income attributable to HCA Healthcare, Inc. rose to $1.591 billion, or $5.93 per diluted share.
Revenues totaled $17.339 billion.
Net income attributable to HCA Healthcare, Inc. was $1.591 billion, or $5.93 per diluted share.
Adjusted EBITDA reached $3.353 billion.
Cash flows from operating activities amounted to $2.469 billion.
Forward Guidance
The Company reaffirmed its 2024 estimated guidance ranges issued on January 30, 2024. The Company’s 2024 guidance contains a number of assumptions, including, among others, the Company’s current expectations regarding patient volumes and payor mix as well as general economic conditions, including inflation, and excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs and impairment of long-lived assets.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...